Revolution Medicines, Inc. Total Assets decreased by 4.3% to $2.25B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.7%, from $2.37B to $2.25B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 32.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth generally indicates business expansion, while a decline may suggest asset liquidation or a contraction in business scale.
This is the sum of all current and non-current assets owned by the company, representing the total resource base availab...
Universal financial metric used by all public companies to define the size of the balance sheet.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $774.05M | $734.98M | $737.99M | $682.77M | $632.80M | $825.91M | $811.93M | $1.07B | $1.07B | $984.23M | $2.06B | $1.91B | $1.81B | $1.76B | $2.56B | $2.37B | $2.43B | $2.25B | $2.35B | $2.25B |
| QoQ Change | — | -5.0% | +0.4% | -7.5% | -7.3% | +30.5% | -1.7% | +32.2% | +0.0% | -8.3% | +109.5% | -7.4% | -5.2% | -2.5% | +45.1% | -7.5% | +2.7% | -7.3% | +4.6% | -4.3% |
| YoY Change | — | — | — | — | -18.2% | +12.4% | +10.0% | +57.2% | +69.7% | +19.2% | +153.9% | +77.8% | +68.4% | +79.1% | +24.1% | +23.9% | +34.3% | +27.7% | -8.0% | -4.7% |